Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HER2 carboxyl-terminal fragments regulate cell migration and cortactin phosphorylation.
García-Castillo J, Pedersen K, Angelini PD, Bech-Serra JJ, Colomé N, Cunningham MP, Parra-Palau JL, Canals F, Baselga J, Arribas J. García-Castillo J, et al. Among authors: pedersen k. J Biol Chem. 2009 Sep 11;284(37):25302-13. doi: 10.1074/jbc.M109.001982. Epub 2009 Jul 8. J Biol Chem. 2009. PMID: 19589785 Free PMC article.
HER2 fragmentation and breast cancer stratification.
Arribas J, Parra-Palau JL, Pedersen K. Arribas J, et al. Among authors: pedersen k. Clin Cancer Res. 2010 Aug 15;16(16):4071-3. doi: 10.1158/1078-0432.CCR-10-1501. Epub 2010 Aug 3. Clin Cancer Res. 2010. PMID: 20682714 Review.
A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers.
Parra-Palau JL, Pedersen K, Peg V, Scaltriti M, Angelini PD, Escorihuela M, Mancilla S, Sánchez Pla A, Ramón Y Cajal S, Baselga J, Arribas J. Parra-Palau JL, et al. Among authors: pedersen k. Cancer Res. 2010 Nov 1;70(21):8537-46. doi: 10.1158/0008-5472.CAN-10-1701. Epub 2010 Oct 26. Cancer Res. 2010. PMID: 20978202
p95HER2 and breast cancer.
Arribas J, Baselga J, Pedersen K, Parra-Palau JL. Arribas J, et al. Among authors: pedersen k. Cancer Res. 2011 Mar 1;71(5):1515-9. doi: 10.1158/0008-5472.CAN-10-3795. Epub 2011 Feb 22. Cancer Res. 2011. PMID: 21343397 Review.
Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence.
Angelini PD, Zacarias Fluck MF, Pedersen K, Parra-Palau JL, Guiu M, Bernadó Morales C, Vicario R, Luque-García A, Navalpotro NP, Giralt J, Canals F, Gomis RR, Tabernero J, Baselga J, Villanueva J, Arribas J. Angelini PD, et al. Among authors: pedersen k. Cancer Res. 2013 Jan 1;73(1):450-8. doi: 10.1158/0008-5472.CAN-12-2301. Cancer Res. 2013. PMID: 23288917
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.
Parra-Palau JL, Morancho B, Peg V, Escorihuela M, Scaltriti M, Vicario R, Zacarias-Fluck M, Pedersen K, Pandiella A, Nuciforo P, Serra V, Cortés J, Baselga J, Perou CM, Prat A, Rubio IT, Arribas J. Parra-Palau JL, et al. Among authors: pedersen k. J Natl Cancer Inst. 2014 Sep 24;106(11):dju291. doi: 10.1093/jnci/dju291. Print 2014 Nov. J Natl Cancer Inst. 2014. PMID: 25253614 Free PMC article.
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer.
Sanz-Moreno A, Palomeras S, Pedersen K, Morancho B, Pascual T, Galván P, Benítez S, Gomez-Miragaya J, Ciscar M, Jimenez M, Pernas S, Petit A, Soler-Monsó MT, Viñas G, Alsaleem M, Rakha EA, Green AR, Santamaria PG, Mulder C, Lemeer S, Arribas J, Prat A, Puig T, Gonzalez-Suarez E. Sanz-Moreno A, et al. Among authors: pedersen k. Breast Cancer Res. 2021 Mar 30;23(1):42. doi: 10.1186/s13058-021-01390-2. Breast Cancer Res. 2021. PMID: 33785053 Free PMC article.
1,608 results